Evotec Investor
Evotec is a drug discovery alliance company providing drug discovery solutions to pharmaceutical and biotechnology companies.
.png)
Funding Status:
IPO
Headquarters:
Hamburg, Hamburg, Germany
Acquisitions Number:
Made Acquisitions
Founded Date:
1993-01-01
Employee Number:
1001-5000
Last Funding Type:
Post-IPO Debt
Total Funding:
733436691.0
Estimated Revenue:
$100M to $500M
Industry:
End-to-End Drug Development
Investors Number:
10.0
Technology:
Biopharma, Biotechnology, Pharmaceutical
Investor Type:
Not Classified
Last Funding Date:
2023-02-10
Number Of Exists:
2